Table 1.
n (%) | ||
---|---|---|
Age (years) | Min-max (median) | 1–71 (44) |
Mean±SD | 41.96±21.88 | |
Sex | Female | 10 (40.0) |
Male | 15 (60.0) | |
Diagnosis | Osteosarcoma | 9 (36.0) |
Ewing sarcoma | 3 (9.0) | |
Pleomorphic sarcoma | 3 (9.0) | |
Chondrosarcoma | 2 (8.0) | |
Fibrosarcoma | 2 (8.0) | |
Dermatofibrosarcoma protuberans | 1 (4.0) | |
Leimyosarcoma | 1 (4.0) | |
Myofibroblastic sarcoma | 1 (4.0) | |
Myxofibrosarcoma | 1 (4.0) | |
Rabdomyosarcoma | 1 (4.0) | |
Synovial Sarcoma | 1 (4.0) | |
Tumor localization | Upper extremity | 6 (24.0) |
Lower extremity | 19 (76.0) | |
Tumor depth | Superficial | 0 (0.0) |
Deep | 25 (100.0) | |
Tumor size (cm) | Min-max (median) | 4–30 (9) |
Mean±SD | 10.20±5.45 | |
Tumor grade | Grade 1 | 4 (16.0) |
Grade 2 | 3 (12.0) | |
Grade 3 | 18 (72.0) | |
Surgical margin | Wide | 16 (64.0) |
Marginal | 5 (20.0) | |
Intralesional | 4 (16.0) | |
Closure of wound | Primary | 18 (72.0) |
STSG | 3 (12.0) | |
Free flap | 4 (16.0) | |
Indications of amputation | Oncological indications | |
Local recurrence | 18 (72.0) | |
Non-oncological indications | ||
Prosthetic infection | 5 (20.0) | |
Mechanic failure | 1 (4.0) | |
Skin necrosis | 1 (4.0) | |
Number of operations before amputation | Min-max (median) | 1–4 (2) |
Mean±SD | 2±0.76 | |
Amputation decision for oncological indications | 1st local recurrence | 4 (22.2) |
2nd local recurrence | 11 (61.1) | |
>2nd local recurrence | 3 (16.7) | |
Metastasis before amputation | Yes | 13 (52.0) |
No | 12(48.0) | |
Metastasis at follow-up | Yes | 22 (88.0) |
No | 3 (12.0) | |
Survival status | Alive | 11 (44.0) |
Dead | 14 (56.0) | |
Follow-up (month) | Min-max (median) | 6–125 (27) |
Mean±SD | 39.88±31.59 |
SD: standard deviation; STSG: split thickness skin graft.